Home
BMRN
BMRN News

Latest BioMarin Pharmaceutical Inc. (BMRN) News on November 22, 2024

Why Is BioMarin Pharmaceutical Inc. (BMRN) Among the Worst Performing Biotech Stocks in 2024?

Insider Monkey

11 hours ago

Why Is BioMarin Pharmaceutical Inc. (BMRN) Among the Worst Performing Biotech Stocks in 2024?

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock

Zacks

19 hours ago

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock

Zacks

2 days ago

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock

BioMarin Pharmaceutical Inc. (BMRN): Among the Best Genomics Stocks to Buy Right Now

Insider Monkey

2 days ago

BioMarin Pharmaceutical Inc. (BMRN): Among the Best Genomics Stocks to Buy Right Now

BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO® (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024

PR Newswire

6 days ago

BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO® (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024

MT Newswires

7 days ago

Wolfe Research Initiates BioMarin Pharmaceutical at Outperform With $95 Price Target

MT Newswires

8 days ago

Biomarin Pharmaceutical Insider Sold Shares Worth $350,324, According to a Recent SEC Filing

Argus Research

9 days ago

BMRN: What does Argus have to say about BMRN?

Implied Volatility Surging for BioMarin Pharmaceutical (BMRN) Stock Options

Zacks

10 days ago

Implied Volatility Surging for BioMarin Pharmaceutical (BMRN) Stock Options

Here’s Why BioMarin Aristotle Large Cap Growth Strategy Divested From Pharmaceutical (BMRN)

Insider Monkey

15 days ago

Here’s Why BioMarin Aristotle Large Cap Growth Strategy Divested From Pharmaceutical (BMRN)

BioMarin to Participate in Three Upcoming Investor Conferences

PR Newswire

16 days ago

BioMarin to Participate in Three Upcoming Investor Conferences

Argus Research

16 days ago

BMRN: Lowering target price to $69.00

Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term

Zacks

17 days ago

Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term

Is BioMarin (BMRN) a Solid Growth Stock? 3 Reasons to Think "Yes"

Zacks

18 days ago

Is BioMarin (BMRN) a Solid Growth Stock? 3 Reasons to Think "Yes"

BioMarin (BMRN) Upgraded to Buy: Here's Why

Zacks

18 days ago

BioMarin (BMRN) Upgraded to Buy: Here's Why

BMRN vs. INCY: Which Stock Is the Better Value Option?

Zacks

18 days ago

BMRN vs. INCY: Which Stock Is the Better Value Option?

Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term

Zacks

18 days ago

Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term

Beyond the Balance Sheet: What SWOT Reveals About Biomarin Pharmaceutical Inc (BMRN)

GuruFocus.com

21 days ago

Beyond the Balance Sheet: What SWOT Reveals About Biomarin Pharmaceutical Inc (BMRN)

BioMarin price target raised to $106 from $104 at UBS

TipRanks

22 days ago

BioMarin price target raised to $106 from $104 at UBS

BioMarin Pharmaceutical Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

22 days ago

BioMarin Pharmaceutical Third Quarter 2024 Earnings: Beats Expectations

Thomson Reuters StreetEvents

23 days ago

Q3 2024 BioMarin Pharmaceutical Inc Earnings Call

BioMarin Q3 Earnings & Revenues Beat Estimates, '24 Guidance Raised

Zacks

23 days ago

BioMarin Q3 Earnings & Revenues Beat Estimates, '24 Guidance Raised

MT Newswires

23 days ago

UBS Adjusts Price Target on BioMarin Pharmaceutical to $106 From $104, Maintains Buy Rating

Morningstar Research

23 days ago

Analyst Report: BioMarin Pharmaceutical Inc.

Biomarin Pharmaceutical Inc (BMRN) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...

GuruFocus.com

23 days ago

Biomarin Pharmaceutical Inc (BMRN) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...

BioMarin (BMRN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

23 days ago

BioMarin (BMRN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

BioMarin Pharmaceutical (BMRN) Tops Q3 Earnings and Revenue Estimates

Zacks

23 days ago

BioMarin Pharmaceutical (BMRN) Tops Q3 Earnings and Revenue Estimates

MT Newswires

24 days ago

BioMarin Pharmaceutical Q3 Non-GAAP Earnings, Revenue Rise; 2024 Forecast Boosted

Associated Press Finance

24 days ago

BioMarin: Q3 Earnings Snapshot

BioMarin Announces 28% Y/Y Total Revenue Growth in the Third Quarter and Increase in Full-year 2024 Guidance; Reaffirms Long-term Guidance and Outlook

PR Newswire

24 days ago

BioMarin Announces 28% Y/Y Total Revenue Growth in the Third Quarter and Increase in Full-year 2024 Guidance; Reaffirms Long-term Guidance and Outlook

Monopar Announces Agreement with Alexion, AstraZeneca Rare Disease For Late-Stage Wilson Disease Drug Candidate

GlobeNewswire

a month ago

Monopar Announces Agreement with Alexion, AstraZeneca Rare Disease For Late-Stage Wilson Disease Drug Candidate

BioMarin Pharmaceutical (BMRN): Hedge Funds Back Biotech Leader Amid Record Revenue Growth

Insider Monkey

a month ago

BioMarin Pharmaceutical (BMRN): Hedge Funds Back Biotech Leader Amid Record Revenue Growth

Blueprint Medicines (BPMC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks

a month ago

Blueprint Medicines (BPMC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zacks

a month ago

BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock

Zacks

a month ago

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock

BioMarin to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Tuesday, October 29, 2024, at 4:30pm ET

PR Newswire

a month ago

BioMarin to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Tuesday, October 29, 2024, at 4:30pm ET

Argus Research

a month ago

BMRN: Lowering target price to $72.00

Do Options Traders Know Something About BioMarin (BMRN) Stock We Don't?

Zacks

2 months ago

Do Options Traders Know Something About BioMarin (BMRN) Stock We Don't?

MT Newswires

2 months ago

RBC Lowers Price Target on BioMarin Pharmaceutical to $80 From $85, Keeps Sector Perform Rating

3 Reasons Why Growth Investors Shouldn't Overlook BioMarin (BMRN)

Zacks

2 months ago

3 Reasons Why Growth Investors Shouldn't Overlook BioMarin (BMRN)

BMRN or MYGN: Which Is the Better Value Stock Right Now?

Zacks

2 months ago

BMRN or MYGN: Which Is the Better Value Stock Right Now?

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Zacks

2 months ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Down -22.94% in 4 Weeks, Here's Why You Should You Buy the Dip in BioMarin (BMRN)

Zacks

2 months ago

Down -22.94% in 4 Weeks, Here's Why You Should You Buy the Dip in BioMarin (BMRN)

Andreas Halvorsen's Strategic Acquisition in BioMarin Pharmaceutical Inc

GuruFocus.com

2 months ago

Andreas Halvorsen's Strategic Acquisition in BioMarin Pharmaceutical Inc

Andreas Halvorsen's Firm Expands Grip in BioMarin Pharmaceutical Inc Holding

GuruFocus.com

2 months ago

Andreas Halvorsen's Firm Expands Grip in BioMarin Pharmaceutical Inc Holding

Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term

Zacks

2 months ago

Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term

High Growth Tech Stocks To Watch For Future Potential

Simply Wall St.

2 months ago

High Growth Tech Stocks To Watch For Future Potential

BioMarin Stands Firm on 2027 Revenue Target Amid Ascendis Competition, Goldman Sachs Analyst Remains Bullish

Benzinga

2 months ago

BioMarin Stands Firm on 2027 Revenue Target Amid Ascendis Competition, Goldman Sachs Analyst Remains Bullish

BioMarin (BMRN): Strong Results and ROCTAVIAN Progress Make It a Mid-Cap Growth Gem

Insider Monkey

2 months ago

BioMarin (BMRN): Strong Results and ROCTAVIAN Progress Make It a Mid-Cap Growth Gem

BioMarin to Present Data Underscoring Sustained Positive Impact of VOXZOGO® (vosoritide) on Health-Related Quality of Life, Growth and Maintenance of Bone Strength in Children with Achondroplasia at 2024 International Skeletal Dysplasia Society Meeting

PR Newswire

2 months ago

BioMarin to Present Data Underscoring Sustained Positive Impact of VOXZOGO® (vosoritide) on Health-Related Quality of Life, Growth and Maintenance of Bone Strength in Children with Achondroplasia at 2024 International Skeletal Dysplasia Society Meeting

Ascendis Soars on Encouraging Data From Dwarfism Drug Study

Zacks

2 months ago

Ascendis Soars on Encouraging Data From Dwarfism Drug Study

Morningstar Research

2 months ago

Analyst Report: BioMarin Pharmaceutical Inc.

MT Newswires

2 months ago

Truist Cuts Price Target on BioMarin Pharmaceutical to $90 From $118, Keeps Buy Rating

Ascendis trial data piles pressure on BioMarin

BioPharma Dive

2 months ago

Ascendis trial data piles pressure on BioMarin

MT Newswires

2 months ago

RBC Cuts Price Target on BioMarin Pharmaceutical to $85 From $100, Keeps Sector Perform Rating

Morningstar Research

2 months ago

Analyst Report: BioMarin Pharmaceutical Inc.

Ascendis Rockets — And Hammers BioMarin — On New Results For Growth Drug

Investor's Business Daily

2 months ago

Ascendis Rockets — And Hammers BioMarin — On New Results For Growth Drug

Despite Being First Mover, BioMarin's Voxzogo For Dwarfism To Face Pressure From Ascendis' Candidate In Near Term

Benzinga

2 months ago

Despite Being First Mover, BioMarin's Voxzogo For Dwarfism To Face Pressure From Ascendis' Candidate In Near Term

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock

Zacks

2 months ago

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock

BioMarin Pharmaceutical Inc. (BMRN): Is This Biotech Stock A Good Buy?

Insider Monkey

2 months ago

BioMarin Pharmaceutical Inc. (BMRN): Is This Biotech Stock A Good Buy?

BioMarin Posts '27 Biz View, Outlines Growth Plans for Next 10 Years

Zacks

3 months ago

BioMarin Posts '27 Biz View, Outlines Growth Plans for Next 10 Years

MT Newswires

3 months ago

Truist Securities Adjusts Price Target on BioMarin Pharmaceutical to $118 From $140, Maintains Buy Rating

BioMarin, having retrenched, outlines plans for growth

BioPharma Dive

3 months ago

BioMarin, having retrenched, outlines plans for growth

BioMarin Holds Investor Day; Provides New Corporate Strategy and Introduces 2027 Financial Guidance

PR Newswire

3 months ago

BioMarin Holds Investor Day; Provides New Corporate Strategy and Introduces 2027 Financial Guidance

Why Is BioMarin (BMRN) Up 5.4% Since Last Earnings Report?

Zacks

3 months ago

Why Is BioMarin (BMRN) Up 5.4% Since Last Earnings Report?

BioMarin to Host Investor Day Today at 10:30 a.m. Eastern Time

PR Newswire

3 months ago

BioMarin to Host Investor Day Today at 10:30 a.m. Eastern Time

Zacks.com featured highlights include Wolverine World Wide, BioMarin Pharmaceutical, Datadog, Progressive and Klaviyo

Zacks

3 months ago

Zacks.com featured highlights include Wolverine World Wide, BioMarin Pharmaceutical, Datadog, Progressive and Klaviyo

Bet on These 5 Stocks With Upgraded Broker Ratings Right Now

Zacks

3 months ago

Bet on These 5 Stocks With Upgraded Broker Ratings Right Now

Exploring Three High Growth Tech Stocks In The United States

Simply Wall St.

3 months ago

Exploring Three High Growth Tech Stocks In The United States

BioMarin lays off 225 employees in restructuring efforts

Pharmaceutical Technology

3 months ago

BioMarin lays off 225 employees in restructuring efforts

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Momentum Stock

Zacks

3 months ago

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Momentum Stock

BioMarin to lay off over 200 employees

BioPharma Dive

3 months ago

BioMarin to lay off over 200 employees

BioMarin to Present at the 22nd Annual Morgan Stanley Global Healthcare Conference on Thursday, September 5 at 7:45 AM PT / 10:45 AM ET in New York, NY

PR Newswire

3 months ago

BioMarin to Present at the 22nd Annual Morgan Stanley Global Healthcare Conference on Thursday, September 5 at 7:45 AM PT / 10:45 AM ET in New York, NY

The most expensive drugs in the US

Pharmaceutical Technology

3 months ago

The most expensive drugs in the US

Is BioMarin (BMRN) a Solid Growth Stock? 3 Reasons to Think "Yes"

Zacks

3 months ago

Is BioMarin (BMRN) a Solid Growth Stock? 3 Reasons to Think "Yes"

Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term

Zacks

3 months ago

Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term

Argus Research

3 months ago

BMRN: Lowering target price to $95.00

Is the Options Market Predicting a Spike in BioMarin (BMRN) Stock?

Zacks

3 months ago

Is the Options Market Predicting a Spike in BioMarin (BMRN) Stock?

BioMarin Announces New R&D and Business Development Leadership

PR Newswire

3 months ago

BioMarin Announces New R&D and Business Development Leadership

BioMarin taps Amgen, Roche vets in executive reshuffle

BioPharma Dive

3 months ago

BioMarin taps Amgen, Roche vets in executive reshuffle

Argus Research

3 months ago

BMRN: Raising target price to $99.00

MT Newswires

3 months ago

BioMarin Pharmaceutical Shares Up After Upgrade From Bernstein

MT Newswires

3 months ago

Bernstein Upgrades BioMarin Pharmaceutical to Outperform From Market Perform

BioMarin to Host 2024 Investor Day on September 4th in New York

PR Newswire

3 months ago

BioMarin to Host 2024 Investor Day on September 4th in New York

Here's Why You Should Invest in BioMarin (BMRN) Stock Now

Zacks

3 months ago

Here's Why You Should Invest in BioMarin (BMRN) Stock Now

Why BioMarin Pharmaceutical (BMRN) is a Top Momentum Stock for the Long-Term

Zacks

3 months ago

Why BioMarin Pharmaceutical (BMRN) is a Top Momentum Stock for the Long-Term

3 US Stocks That May Be Undervalued According To Estimates

Simply Wall St.

3 months ago

3 US Stocks That May Be Undervalued According To Estimates

BioMarin (BMRN) is an Incredible Growth Stock: 3 Reasons Why

Zacks

3 months ago

BioMarin (BMRN) is an Incredible Growth Stock: 3 Reasons Why

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Zacks

3 months ago

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

BioMarin Pharmaceutical Inc (BMRN): Are Hedge Funds Bullish on This Elliott Management-Approved Stock Now?

Insider Monkey

3 months ago

BioMarin Pharmaceutical Inc (BMRN): Are Hedge Funds Bullish on This Elliott Management-Approved Stock Now?

BioMarin Pharmaceutical Second Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

3 months ago

BioMarin Pharmaceutical Second Quarter 2024 Earnings: Beats Expectations

When Product Launches Struggle, Biotech Investors Reward Cost Cuts

The Wall Street Journal

4 months ago

When Product Launches Struggle, Biotech Investors Reward Cost Cuts

Thomson Reuters StreetEvents

4 months ago

Q2 2024 Biomarin Pharmaceutical Inc Earnings Call

MT Newswires

4 months ago

BioMarin Pharmaceutical Reports Strong Q2 Driven by Voxzogo Sales, RBC Says

Morningstar Research

4 months ago

Analyst Report: BioMarin Pharmaceutical Inc.

BioMarin (BMRN) Q2 Earnings & Sales Top Estimates, Ups '24 View

Zacks

4 months ago

BioMarin (BMRN) Q2 Earnings & Sales Top Estimates, Ups '24 View

MT Newswires

4 months ago

Evercore ISI Lifts Price Target on BioMarin Pharmaceutical to $115 From $113, Keeps Outperform Rating

BioMarin pares Roctavian spending as it narrows sales focus

BioPharma Dive

4 months ago

BioMarin pares Roctavian spending as it narrows sales focus

BioMarin (BMRN) Reports Q2 Earnings: What Key Metrics Have to Say

Zacks

4 months ago

BioMarin (BMRN) Reports Q2 Earnings: What Key Metrics Have to Say

BioMarin Pharmaceutical (BMRN) Q2 Earnings and Revenues Surpass Estimates

Zacks

4 months ago

BioMarin Pharmaceutical (BMRN) Q2 Earnings and Revenues Surpass Estimates

Share on Social Networks: